The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
ASAP CRN 2025 RFA Scientific Track, 2026CLEAR-PD: Clearance via Lymphatics & Endocytic Alpha-Synuclein Receptors in Parkinson’s Disease
Study Rationale:
In Parkinson’s disease (PD), it is clear that the alpha-synuclein protein accumulates in specific neurons, thereby damaging them to cause neurological symptoms...
-
ASAP CRN 2025 RFA Scientific Track, 2026Decoding Co-Pathological Mechanisms in Parkinson's Disease: From Molecular Interactions to Disease Progression
Study Rationale:
Parkinson's disease involves multiple abnormal proteins—α-synuclein, tau, and TDP-43—that clump together in brain cells. These protein clumps don't act alone; they work...
-
ASAP CRN 2025 RFA Scientific Track, 2026Deciphering the Aggregatome: Unraveling Alpha-Synuclein Seeding Drivers in Parkinson’s Disease Across Human Biomaterials
Study Rationale:
Parkinson's disease affects people very differently. Some patients progress quickly and develop severe symptoms within a few years, while others remain stable...
-
ASAP CRN 2025 RFA Scientific Track, 2026Defining Functional Heterogeneity Within the Subthalamic Area and Its Relevance for Psychiatric Symptoms of PD
Study Rationale:
Anxiety, depression, reduced motivation, and impaired cognition are common symptoms in Parkinson’s disease (PD), often occurring early in its course, before...
-
ASAP CRN Discovery Fellowship 2025, 2026Targeting Rubicon to Restore Lysosomal and Autophagic Health in LRRK2 Mediated Parkinson’s Disease
Study Rationale:
Parkinson’s disease develops in part because brain cells lose the ability to clear away damaged proteins and cell parts, leading to stress and cell death. A...
-
ASAP CRN Discovery Fellowship 2025, 2026Cryo-ET and Lipidomics of Lysosome Damage in Familial and Sporadic Parkinson’s Disease
Study Rationale:
Parkinson’s disease (PD) is driven by many factors, but a common feature is the buildup of a sticky protein called alpha-synuclein. These protein clumps can...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.